SHC 📈 Sotera Health - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US83601L1026
SHC: Sterilization Services, Lab Testing, Advisory Services
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. Web URL: https://soterahealth.com
Additional Sources for SHC Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SHC Stock Overview
Market Cap in USD | 3,710m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 2020-11-20 |
SHC Stock Ratings
Growth 5y | -61.5% |
Fundamental | 37.6% |
Dividend | - |
Rel. Strength Industry | -946 |
Analysts | 4/5 |
Fair Price Momentum | 11.08 USD |
Fair Price DCF | 6.53 USD |
SHC Dividends
No Dividends PaidSHC Growth Ratios
Growth Correlation 3m | -79.2% |
Growth Correlation 12m | 8.6% |
Growth Correlation 5y | -81% |
CAGR 5y | -14.47% |
CAGR/Mean DD 5y | -0.39 |
Sharpe Ratio 12m | -0.50 |
Alpha | -59.74 |
Beta | 1.62 |
Volatility | 38.42% |
Current Volume | 3232.1k |
Average Volume 20d | 1675.3k |
What is the price of SHC stocks?
As of December 21, 2024, the stock is trading at USD 13.24 with a total of 3,232,138 shares traded.
Over the past week, the price has changed by -0.97%, over one month by -2.50%, over three months by -19.82% and over the past year by -19.72%.
As of December 21, 2024, the stock is trading at USD 13.24 with a total of 3,232,138 shares traded.
Over the past week, the price has changed by -0.97%, over one month by -2.50%, over three months by -19.82% and over the past year by -19.72%.
Is Sotera Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Sotera Health (NASDAQ:SHC) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.55 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SHC as of December 2024 is 11.08. This means that SHC is currently overvalued and has a potential downside of -16.31%.
Partly, yes. Based on ValueRay Fundamental Analyses, Sotera Health (NASDAQ:SHC) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.55 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SHC as of December 2024 is 11.08. This means that SHC is currently overvalued and has a potential downside of -16.31%.
Is SHC a buy, sell or hold?
Sotera Health has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy SHC.
Sotera Health has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy SHC.
- Strong Buy: 3
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecast for SHC stock price target?
According to ValueRays Forecast Model, SHC Sotera Health will be worth about 12.2 in December 2025. The stock is currently trading at 13.24. This means that the stock has a potential downside of -8.01%.
According to ValueRays Forecast Model, SHC Sotera Health will be worth about 12.2 in December 2025. The stock is currently trading at 13.24. This means that the stock has a potential downside of -8.01%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 16.9 | 27.3% |
Analysts Target Price | 20 | 51.1% |
ValueRay Target Price | 12.2 | -8% |